Wednesday 21st March, 2012
11:15am to 12:15pm
Since FDA letters to pharmaceutical companies began arriving in 2009, and with constantly increasing scrutiny towards online marketing, many regulated industries have been forced to look for ways to modify their legal terms for marketing and partnering with agencies and other 3rd party vendors. This session will address the following:
Legal rules for regulated industries such as Healthcare/Pharmaceutical, Financial Services, and B2B, B2G
Interpretations and discussion around how Internet Marketing laws are incorporated into campaign planning and execution
Can a pharmaceutical company comfortably solicit inbound links in support of SEO?
Should Financial Services companies be limited from using terms such as "best rates?
information privacy/corporate lawyer, CIPP and (benevolent) dictator in training. I tweet about #privacy issues and life's vagaries bio from Twitter
WSJ reporter covering antitrust, Justice Department and other Washington/business/legal stuff. bio from Twitter
Interactive marketing expert, President of SEMPO, father, fantasy sports fanatic. Redskins, Caps, Dodgers and Lakers fan. bio from Twitter
Sign in to add slides, notes or videos to this session